Biondvax Pharmaceuticals Ltd - ADR

NASDAQ:BVXV   3:59:53 PM EDT
2.36
-0.01 (-0.42%)
Earnings Announcements

BiondVax Announces Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/26/2021 20:27 GMT
Biondvax Pharmaceuticals Ltd - ADR (BVXV) - Biondvax Announces Second Quarter 2021 Financial Results and Provides Business Update.
Biondvax Pharmaceuticals Ltd - Qtrly Loss per Share Nis 0.03.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.